These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tinea faciei in a central Portuguese hospital: A 9-year survey. Borges A, Brasileiro A, Galhardas C, Apetato M. Mycoses; 2018 Apr; 61(4):283-285. PubMed ID: 29285801 [Abstract] [Full Text] [Related]
5. Deep facial mycosis due to Trichophyton verrucosum-molecular genetic identification of the dermatophyte in paraffin-embedded tissue-case report and review of the literature. Wollina U, Hansel G, Uhrlaß S, Krüger C, Schönlebe J, Hipler UC, Nenoff P. Mycoses; 2018 Mar; 61(3):152-158. PubMed ID: 29082569 [Abstract] [Full Text] [Related]
9. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study. Voravutinon V. J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640 [Abstract] [Full Text] [Related]
12. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo. Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG. Dermatology; 1998 Jul; 197(4):361-7. PubMed ID: 9873175 [Abstract] [Full Text] [Related]
16. Tinea capitis in adults in southern Spain. A 17-year epidemiological study. Lova-Navarro M, Gómez-Moyano E, Martínez Pilar L, Fernandez-Ballesteros MD, Godoy-Díaz DJ, Vera-Casaño A, Crespo-Erchiga V. Rev Iberoam Micol; 2016 Jul; 33(2):110-3. PubMed ID: 26774593 [Abstract] [Full Text] [Related]